Serina Therapeutics, Inc. (SER) Gross profit 2017–2023
Serina Therapeutics, Inc. (SER) annual gross profit history from SEC filings — each fiscal year as reported.
$102,000FY2023 · since FY2017: $1.2M → $102,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $102,000 | +385.7% |
| FY2022 | $21,000 | -83.2% |
| FY2021 | $125,000 | -62.7% |
| FY2020 | $335,000 | -77.4% |
| FY2019 | $1.5M | +43.8% |
| FY2018 | $1.0M | -16.5% |
| FY2017 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice